Serial Number 90674766
Registration 6920786
700

Registration Progress

Application Filed
Apr 27, 2021
Under Examination
Approved for Publication
Sep 27, 2022
Published for Opposition
Sep 27, 2022
Registered
Dec 13, 2022

Trademark Image

Basic Information

Serial Number
90674766
Registration Number
6920786
Filing Date
April 27, 2021
Registration Date
December 13, 2022
Published for Opposition
September 27, 2022
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 13, 2022
Registration
Registered
Classes
005

Rights Holder

AstraZeneca UK Limited

16
Address
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB20AA
GB

Ownership History

AstraZeneca UK Limited

Original Applicant
16
Cambridge GB

AstraZeneca UK Limited

Owner at Publication
16
Cambridge GB

AstraZeneca UK Limited

Original Registrant
16
Cambridge GB

Legal Representation

Attorney
Wm. Charles Saunders

USPTO Deadlines

Next Deadline
1061 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20221213)
Due Date
December 13, 2028
Grace Period Ends
June 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Dec 13, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 13, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 27, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 27, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 7, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 25, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 30, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 29, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 29, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 12, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 12, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 13, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 13, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 11, 2022 ALIE A ASSIGNED TO LIE Loading...
Apr 6, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 23, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 23, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 23, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 22, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 3, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 2, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 22, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 22, 2021 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jul 22, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 22, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 30, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances, namely, vaccines

Additional Information

Design Mark
The mark consists of geometric shapes consisting of three rows of an arrangement of cylinders with hemispherical ends and a dot at the point of the shapes. The top row consists of four cylinders pointing outwards with hemispherical ends and a dot at the point with two intersecting at the dot at the point of the shapes in the center of the row. The middle row consists of eight cylinders pointing outwards with hemispherical ends and a dot at the point with four intersecting at the dot at the point of the shapes in the center of the row. The bottom row consists of four cylinders pointing outwards with hemispherical ends and a dot at the point with two intersecting at the dot at the point of the shapes in the center of the row.

Classification

International Classes
005